Search
for

    Glossary Olanzapine

    antipsychotic medication used to treat schizophrenia and bipolar disorder

    Olanzapine, also known by the brand name Zyprexa, is an antipsychotic medication used to treat mental health conditions such as schizophrenia and bipolar disorder. It works by altering the activity of certain neurotransmitters in the brain, helping to reduce symptoms like hallucinations, delusions, and mood swings.

    Sort by

    Research 30 of 146

    1. Olanzapine counteracts stress-induced anxiety-like behavior in rats Neuroscience Letters · 2008 · 27 citations
    2. Olanzapine Induced Hair Loss: A Case Report Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · 2012 · 9 citations
    3. Olanzapine-Induced Hair Loss 2002 · 8 citations
    4. Treatment of Delusional Infestation with Olanzapine Indian Journal of Psychological Medicine · 2012 · 3 citations
    5. Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications Hospital pharmacy · 2007
    6. Trichotillomania American Journal of Psychiatry · 2016 · 219 citations
    7. Recent advances in the treatment of trichotillomania (hair‐pulling disorder) Dermatologic Therapy · 2020 · 24 citations
    8. Diagnosis and treatment of trichotillomania Neuropsychiatry · 2011 · 3 citations
    9. Actualización en el tratamiento de la tricotilomanía Actas Dermo-Sifiliográficas · 2024
    10. Actualización en el tratamiento de la tricotilomanía 2024
    11. A case of telogen effluvium associated with drug-induced hyperprolactinemia. Nihon rinsho hifukaikai zasshi · 2020
    12. Trichotillomania. Apollo (University of Cambridge) · 2016
    13. Reporting on Adverse Clinical Events Clin-Alert · 2010
    14. Anorexia Nervosa and Gender Dysphoria: A Clinical Case European Psychiatry · 2022
    15. Abstract- Poster 2022
    16. P.3.a.011 Dietary intake in subjects with early psychosis: is there a relationship with clinical subtype or antipsychotic treatment? European Neuropsychopharmacology · 2012
    17. Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare 2023 · 1 citations
    18. END OF LIFE CARE IN INPATIENT PSYCHIATRY: A CASE STUDY ON END-STAGE ALZHEIMER'S DISEASE 2019 · 1 citations
    19. Alopecia associated with quetiapine International Clinical Psychopharmacology · 2007 · 19 citations
    20. Adverse Cutaneous Reactions to Antipsychotics American Journal of Clinical Dermatology · 2002 · 64 citations
    21. Finasteride-induced depression: new insights into possible pathomechanisms Journal of Cosmetic Dermatology · 2010 · 22 citations
    22. A double-blind, placebo-controlled study of inositol in trichotillomania International clinical psychopharmacology · 2016 · 18 citations
    23. Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research Journal of Neuroendocrinology · 2015 · 123 citations
    24. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    25. Assessment of the obese patient Endocrinology and Metabolism Clinics of North America · 2003 · 66 citations
    26. Emerging treatments in alopecia Expert Opinion on Emerging Drugs · 2014 · 47 citations
    27. Drug-Induced Hair Disorders Current Drug Safety · 2006 · 40 citations
    28. Psychocutaneous disease Journal of The American Academy of Dermatology · 2017 · 38 citations
    29. Finasteride Treatment Inhibits Adult Hippocampal Neurogenesis in Male Mice Pharmacopsychiatry · 2010 · 32 citations
    30. Enhanced remyelination during late pregnancy: involvement of the GABAergic system Scientific Reports · 2019 · 30 citations